Clinical trials
Completed Phase 4 Lung Diseases, Interstitial trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Daniel Franzen | 1 |
| Duke University | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| KU Leuven | 1 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | 1 |
| Rohit Aggarwal, MD | 1 |
| Turkish Thoracic Society | 1 |
| University of Aarhus | 1 |
| University of Cincinnati | 1 |
| University of Zurich | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases, Interstitial | 10 |
| Sarcoidosis | 3 |
| COVID-19 | 2 |
| Dyspnea | 2 |
| Pulmonary Fibrosis | 2 |
| Cicatrix | 1 |
| Fibrosis | 1 |
| Heart Failure | 1 |
| Hepatitis C, Chronic | 1 |
| Hypertension, Pulmonary | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.